Drug Profile
ET 08
Alternative Names: ET-08Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator ExoCyte Therapeutics
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Cytotoxic T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Oct 2021 No recent reports of development identified for research development in Cancer in Singapore (Parenteral, Injection)
- 18 Sep 2017 Early research in Cancer in Singapore (Parenteral) (Exocyte Therapeutics pipeline, September 2017)